SEC Filing Details

Document Details

Form
Filing Date
Jul 12, 2022
Document Date
Jul 12, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.
Filer
MAYO STEPHEN
Print Page
Email Alerts
RSS Feeds
Investor Contacts